《10-Year Hits 5% as Fed Meeting Kicks Off | PreMarket Playbook + T3 Live | September 15, 2026》
GTBP 面临历史反向拆股带来的风险，以及为临床试验融资所需的未来增发/摊薄预期。
我们今天能看一下GT Biopharma吗？它一直处于不错的上升趋势中。可以，我们完全可以看一下。我确实看到它基本上涨到了它的200日线。所以，我们看看GTBP今天怎么走。我把它放到另一个窗口里了。
如果到了股票环节我忘了，提醒我一下。我们会讲到它的。
Can we take a look at GT Biioarma today? It's been on a nice uptrend. Yeah, we can absolutely take a look at that. I did see that it basically traded up to its 200 day. So, um we'll see what uh GTBP does here today.
I did put it in another window. If I forget when we get to the stock section, remind me. We'll get to that.